ERBB2 and neoplasm: Anti-ECD/Her2 antibodies were not present in control mice which were injected with PBS, while the increased background level 30 days after the tumor challenge (day 82-see below) is due to the Her2/neu molecule that is expressed in the surface of D2F2/E2 transfected cell lines.